AIMC Topic: Cognitive Dysfunction

Clear Filters Showing 51 to 60 of 613 articles

Accurate deep-learning model to differentiate dementia severity and diagnosis using a portable electroencephalography device.

Scientific reports
Mild cognitive impairment (MCI) and dementia pose significant health challenges in aging societies, emphasizing the need for accessible, cost-effective, and noninvasive diagnostic tools. Electroencephalography (EEG) is a promising biomarker, but trad...

Multimodal neuroimaging unveils basal forebrain-limbic system circuit dysregulation in cognitive impairment with depression: a pathway to early diagnosis and intervention.

The journal of prevention of Alzheimer's disease
BACKGROUND: Alzheimer's disease (AD) frequently co-occurs with depressive symptoms, exacerbating both cognitive decline and clinical complexity, yet the neural substrates linking this co-occurrence remain poorly understood. We aimed to investigate th...

Developing an explainable machine learning and fog computing-based visual rating scale for the prediction of dementia progression.

Scientific reports
Recently, dementia research has primarily concentrated on using Magnetic Resonance Imaging (MRI) to develop learning models in processing and analyzing brain data. However, these models often cannot provide early detection of affected brain regions. ...

Evaluating cognitive decline detection in aging populations with single-channel EEG features based on two studies and meta-analysis.

Scientific reports
Timely detection of cognitive decline is paramount for effective intervention, prompting researchers to leverage EEG pattern analysis, focusing particularly on cognitive load, to establish reliable markers for early detection and intervention. This c...

Enhancing automated detection and classification of dementia in individuals with cognitive impairment using artificial intelligence techniques.

Scientific reports
Dementia is a degenerative and chronic disorder, increasingly prevalent among older adults, posing significant challenges in providing appropriate care. As the number of dementia cases continues to rise, delivering optimal care becomes more complex. ...

Machine-learning based strategy identifies a robust protein biomarker panel for Alzheimer's disease in cerebrospinal fluid.

Alzheimer's research & therapy
BACKGROUND: The complex pathogenesis of Alzheimer's disease (AD) has resulted in limited current biomarkers for its classification and diagnosis, necessitating further investigation into reliable universal biomarkers or combinations.

Design of a Mobile App and a Clinical Trial Management System for Cognitive Health and Dementia Risk Reduction: User-Centered Design Approach.

JMIR aging
BACKGROUND: The rising prevalence of dementia is a major concern, with approximately 45% of cases linked to 14 modifiable risk factors. The European project LETHE aims to develop a personalized digital intervention model to delay or prevent cognitive...

Developed a knowledge base of risk factors for postoperative cognitive dysfunction: a retrospective database study.

Scientific reports
Postoperative cognitive dysfunction (POCD), a heterogeneous spectrum of surgery/anesthesia-associated neurocognitive impairments, represents a critical clinical challenge due to its associations with prolonged hospitalization, increased mortality, an...

Machine learning model for predicting Amyloid-β positivity and cognitive status using early-phase F-Florbetaben PET and clinical features.

Scientific reports
This study developed machine learning models to predict Aβ positivity in Alzheimer's disease by integrating early-phase F-Florbetaben PET and clinical data to improve diagnostic accuracy. Furthermore, the study explored machine learning models to pre...

Early detection of Alzheimer's disease using small RNAs. Results from the EPAD cohort.

The journal of prevention of Alzheimer's disease
BACKGROUND: Alzheimer's disease (AD) is the most common form of dementia, and early diagnosis is crucial to enable effective interventions. Currently, Alzheimer's disease is diagnosed through cognitive assessments, brain imaging and fluid biomarkers ...